414 related articles for article (PubMed ID: 26191242)
1. Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients.
Guo S; Chen W; Luo Y; Ren F; Zhong T; Rong M; Dang Y; Feng Z; Chen G
Int J Clin Exp Pathol; 2015; 8(5):5395-402. PubMed ID: 26191242
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
Peng W; Fan H
Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA UC001kfo promotes hepatocellular carcinoma proliferation and metastasis by targeting α-SMA.
Pan Y; Qin T; Yin S; Zhang X; Gao X; Mu L
Biomed Pharmacother; 2017 Mar; 87():669-677. PubMed ID: 28088733
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular Carcinoma and Nuclear Paraspeckles: Induction in Chemoresistance and Prediction for Poor Survival.
Kessler SM; Hosseini K; Hussein UK; Kim KM; List M; Schultheiß CS; Schulz MH; Laggai S; Jang KY; Kiemer AK
Cell Physiol Biochem; 2019; 52(4):787-801. PubMed ID: 30946555
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis.
Zhang M; Wang W; Li T; Yu X; Zhu Y; Ding F; Li D; Yang T
Biomed Pharmacother; 2016 May; 80():73-79. PubMed ID: 27133041
[TBL] [Abstract][Full Text] [Related]
8. NEAT1 promotes cell proliferation and invasion in hepatocellular carcinoma by negative regulating miR-613 expression.
Wang Z; Zou Q; Song M; Chen J
Biomed Pharmacother; 2017 Oct; 94():612-618. PubMed ID: 28783584
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of LncRNA SRA1 in hepatocellular carcinoma and its clinical significance.
Luo P; Jing W; Zhu M; Li ND; Zhou H; Yu MX; Liang CZ; Tu JC
Cancer Biomark; 2017; 18(3):285-290. PubMed ID: 28085012
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA NEAT1 overexpression is associated with unfavorable prognosis in patients with hepatocellular carcinoma after hepatectomy: A Chinese population-based study.
Liu Z; Chang Q; Yang F; Liu B; Yao HW; Bai ZG; Pu CS; Ma XM; Yang Y; Wang TT; Guo W; Zhou XN; Zhang ZT
Eur J Surg Oncol; 2017 Sep; 43(9):1697-1703. PubMed ID: 28732670
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
[TBL] [Abstract][Full Text] [Related]
12. HOX Antisense lincRNA HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma.
Wang F; Yang H; Deng Z; Su Y; Fang Q; Yin Z
Cell Physiol Biochem; 2016; 40(1-2):287-296. PubMed ID: 27855366
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK/MAPK pathway.
Peng W; Fan H
Biomed Pharmacother; 2016 Oct; 83():450-455. PubMed ID: 27427851
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Long Non-Coding RNA PlncRNA-1 Promotes Metastasis and Induces Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.
Dong L; Ni J; Hu W; Yu C; Li H
Cell Physiol Biochem; 2016; 38(2):836-46. PubMed ID: 26906068
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
16. Silencing of long non‑coding RNA NEAT1 inhibits hepatocellular carcinoma progression by downregulating SMO by sponging microRNA‑503.
Sun C; Xiao T; Xiao Y; Li Y
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33398379
[TBL] [Abstract][Full Text] [Related]
17. lncRNA SNHG8 Promotes the Tumorigenesis and Metastasis by Sponging miR-149-5p and Predicts Tumor Recurrence in Hepatocellular Carcinoma.
Dong J; Teng F; Guo W; Yang J; Ding G; Fu Z
Cell Physiol Biochem; 2018; 51(5):2262-2274. PubMed ID: 30537734
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition.
Liu J; Lu C; Xiao M; Jiang F; Qu L; Ni R
Biomed Pharmacother; 2017 May; 89():857-863. PubMed ID: 28282787
[TBL] [Abstract][Full Text] [Related]
19. lncRNA NEAT1 regulates the proliferation and migration of hepatocellular carcinoma cells by acting as a miR‑320a molecular sponge and targeting L antigen family member 3.
Zhang Y; Huang C; Zhu Z; Hou Y; Huang S; Sun C; Tang Y; Zhang Z; Wang L; Chen H; Ju W; Qiao X; Chen M
Int J Oncol; 2020 Oct; 57(4):1001-1012. PubMed ID: 32945386
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation.
Liu X; Liang Y; Song R; Yang G; Han J; Lan Y; Pan S; Zhu M; Liu Y; Wang Y; Meng F; Cui Y; Wang J; Zhang B; Song X; Lu Z; Zheng T; Liu L
Mol Cancer; 2018 May; 17(1):90. PubMed ID: 29764424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
